Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Santiago Sánchez-Cabús is active.

Publication


Featured researches published by Santiago Sánchez-Cabús.


Liver Transplantation | 2013

Importance of the Temporary Portocaval Shunt During Adult Living Donor Liver Transplantation

Santiago Sánchez-Cabús; Constantino Fondevila; David Calatayud; Joana Ferrer; Pilar Taura; José Fuster; Juan Carlos García-Valdecasas

Adult living donor liver transplantation (aLDLT) is associated with surgical risks for the donor and with the possibility of small‐for‐size syndrome (SFSS) for the recipient, with both events being of great importance. An excessively small liver graft entails a relative increase in the portal blood flow during reperfusion, and this factor predisposes the recipient to an increased risk of SFSS in the postoperative period, although other causes related to recipient, graft, and technical factors have also been reported. A hemodynamic monitoring protocol was used for 45 consecutive aLDLT recipients. After various hemodynamic parameters before reperfusion were analyzed, a significant correlation between the temporary portocaval shunt flow during the anhepatic phase and the portal vein flow (PVF) after reperfusion of the graft (R2 = 0.3, P < 0.001) was found, and so was a correlation between the native liver portal pressure and PVF after reperfusion (R2 = 0.21, P = 0.007). The identification of patients at risk for excessive portal hyperflow will allow its modulation before reperfusion. This could favor the use of smaller grafts and ultimately lead to a reduction in donor complications because it would allow more limited hepatectomies to be performed. Liver Transpl 19:174–183, 2013.


Hpb | 2015

Results of laparoscopic radiofrequency ablation for HCC. Could the location of the tumour influence a complete response to treatment? A single European centre experience

Sofía de la Serna; Ramon Vilana; Santiago Sánchez-Cabús; David Calatayud; Joana Ferrer; Víctor Molina; Constantino Fondevila; Jordi Bruix; Josep Fuster; J.C. Garcia-Valdecasas

INTRODUCTION In selected patients, radiofrequency ablation (RFA) is a well-established treatment for hepatocellular carcinoma (HCC). However, subcapsular or lesions close to adjacent viscera preclude a percutaneous approach. In this setting laparoscopic-RFA (LRFA) is a potential alternative. The aim of this study was to analyse the safety and feasibility of LRFA in patients with HCC. PATIENTS AND METHODS Retrospective study of patients with HCC meeting strict inclusion criteria who underwent LRFA at a single Institution from December 2000 to March 2013. RESULTS Forty-one patients underwent 42 LRFA of 51 nodules. The median size of the nodule was 2.5 (range 1.2-4.7) cm. Thirty-one tumours were subcapsular and 17 located near the gallbladder. Major complications occurred in 17 patients. The initial complete response (ICR) rate was 94% and was lower among tumours located adjacent to the gallbladder. At the end of the follow-up period, the sustained complete response (SCR) rate was 70% and was lower in tumours adjacent to the gallbladder while increased for subcapsular tumours. The 1-, 3- and 5-year overall survival rate was 92.6%, 64.5% and 43%, respectively. CONCLUSION LRFA of HCC is safe, feasible and achieves excellent results in selected patients. LRFA should be the first-line technique for subcapsular lesions as it minimizes the risk of tumoural seeding and improves ICR. Proximity to gallbladder interferes in treatment efficacy (lower rate of ICR and lower rate of SCR).


Liver Transplantation | 2017

Effects of alfapump™ system on kidney and circulatory function in patients with cirrhosis and refractory ascites

Elsa Solà; Santiago Sánchez-Cabús; Ezequiel Rodríguez; Chiara Elia; R. Cela; Rebeca Moreira; Elisa Pose; Jordi Sánchez-Delgado; Nuria Cañete; Manuel Morales-Ruiz; Francisco Campos; Jaume Balust; Mónica Guevara; Juan Carlos García-Valdecasas; Pere Ginès

The alfapump system has been proposed as a new treatment for the management of refractory ascites. The system removes ascites from the peritoneal cavity to urinary bladder, producing a continuous low‐volume paracentesis. The aim of the study is to investigate the effects of treatment with the alfapump™ system on kidney and circulatory function in patients with cirrhosis and refractory ascites. This was a prospective study including 10 patients with cirrhosis and refractory ascites. Primary outcomes were changes in glomerular filtration rate (GFR), as assessed by isotopic techniques, and changes in circulatory function assessed by arterial pressure, cardiac output, and activity of vasoconstrictor systems. Secondary outcomes were the need for large‐volume paracentesis and adverse events. Follow‐up was 1 year. GFR decreased significantly from 67 mL/minute/1.73 m2 (41‐90 mL/minute/1.73 m2) at baseline to 45 mL/minute/1.73 m2 (36‐74 mL/minute/1.73 m2) at month 6 (P = 0.04). Mean arterial pressure and cardiac output did not change significantly; however, there was a marked increase in plasma renin activity and norepinephrine concentration (median percent increase with respect to baseline +191% and 59%, respectively). There were 68 episodes of complications of cirrhosis in 8 patients during follow‐up, the most frequent being acute kidney injury. In conclusion, treatment with alfapump™ system was associated with marked activation of endogenous vasoconstrictor systems and impairment of kidney function. The chronological relationship observed between kidney impairment and vasoconstrictor systems activation after device insertion suggests a cause‐effect relationship, raising the possibility that treatment with alfapump impairs effective arterial blood volume mimicking a postparacentesis circulatory dysfunction syndrome. In this context, the potential role of albumin in counteracting these effects should be investigated in future studies. Liver Transplantation 23 583–593 2017 AASLD.


European Surgical Research | 2016

Beneficial Effect of a Resorbable Biliary Stent in Living Donor Liver Transplantation

Santiago Sánchez-Cabús; David Calatayud; Joana Ferrer; Víctor Molina; Mihai-Calin Pavel; Jaime Sampson; David Saavedra; Constantino Fondevila; Josep Fuster; Juan Carlos García-Valdecasas

Background: Living donor liver transplantation (LDLT) entails a significant number of bile duct complications. We aimed to diminish the biliary complication rate with the use of a resorbable biliary stent (RBS) during LDLT. The objective of this study is to describe the surgical techniques and the associated outcomes, especially in terms of safety, of RBS use in LDLT. Methods: From 2011 to 2014, 12 LDLT recipients were enrolled in a clinical trial with the use of a specifically designed RBS. These patients were followed according to the clinical protocol. Specific complications derived from RBS as well as biliary complications were recorded. Results: One patient underwent early retransplantation due to a small-for-size syndrome. None of the patients had a complication attributable to the placement, remaining in place, or degradation of the stent. Four of the remaining patients presented with a biliary complication: 1 (9.1%) with a biliary leak alone, 1 (9.1%) with a biliary stenosis alone, and 2 (18.2%) with both. However, none of the leaks could be directly attributed to the RBS. Patient and graft 1-year survival was 100 and 91.7%, respectively. Conclusion: The use of an RBS in LDLT is not associated with complications, and initial results regarding efficacy and safety are encouraging. The need for a larger and prospective study is warranted.


Langenbeck's Archives of Surgery | 2017

Surgical treatment of perihilar cholangiocarcinoma: early results of en bloc portal vein resection

Víctor Molina; Jaime Sampson; Joana Ferrer; Alba Díaz; Juan Ramón Ayuso; Santiago Sánchez-Cabús; Josep Fuster; Juan Carlos García-Valdecasas

ObjectiveThe objective of this study was to analyse the safety, feasibility and survival outcomes of our treatment of perihilar cholangiocarcinoma (PHC) since the introduction of more aggressive approaches (en bloc, vascular and extended liver resections) in 2007.Patients and methodsFrom July 2007 to December 2014, 32 consecutive patients with PHC underwent surgery with curative intent. Surgery with resection and reconstruction of the portal vein bifurcation and right hepatic artery was performed if necessary for a complete removal of the tumour. Perioperative data and postoperative histological findings, tumour recurrence rates and survival rates were recorded. Seventeen (53%) of the patients presented with stage IIIb or IV according to the UICC classification system.ResultsThe 5-year survival rate in our series was 45%, and this percentage increased to 65% when patients with advanced stage cancer (stage IIIb or higher) were excluded. We performed 3 arterials and 23 portal vein reconstruction. Twelve patients underwent extended hemihepatectomy. We achieved cancer-free margins in 19 patients (60%). Tumour stage and nodal involvement were the most important prognostic factors. The perioperative morbidity and mortality rates of this cohort were 72% (23) and 15.6% (5), respectively; these results were similar to data published by other groups.ConclusionsAn aggressive approach involving en bloc or extended liver resection combined with vascular reconstruction provides acceptable morbidity and mortality and increases the 5-year survival rate of PHC.


Transplantation | 2014

Lack of correlation between preoperative and intraoperative liver hemodynamics: a descriptive analysis.

Santiago Sánchez-Cabús; Juan G. Abraldes; Pilar Taura; David Calatayud; Constantino Fondevila; José Fuster; Joana Ferrer; Juan Carlos García-Pagán; Juan Carlos García-Valdecasas

Background Adult living-donor liver transplantation recipients undergo important hemodynamic changes during the procedure, which in turn have proven to be of the upmost importance when dealing with small grafts, to avoid the so-called “small-for-size” syndrome. Methods Back in 2003, we started a hemodynamic monitoring protocol in adult living-donor liver transplantation recipients, which evaluated the hemodynamic status of the patient 24 hr before, during, and 3 days after transplantation. We analyzed the correlation between the same hemodynamic variables measured in the hemodynamic laboratory and those taken in the operating room. Results With the exception of cardiac index and indexed systemic vascular resistance, all the other hepatic and systemic hemodynamic parameters measured before and during the intervention, as well as during and after the intervention, showed a lack of correlation. Conclusion The observed lack of correlation may happen due to many factors, such as the influence of vasoactive and anesthetic drugs, total muscular relaxation, or the presence of an open abdomen. As a result, a direct comparison between hemodynamic values should only be done when measured in the same conditions.


Cirugia Espanola | 2015

Tumor de Klatskin: Diagnóstico, evaluación preoperatoria y consideraciones quirúrgicas

Víctor Molina; Jaime Sampson; Joana Ferrer; Santiago Sánchez-Cabús; David Calatayud; Mihai Pavel; Constantino Fondevila; José Fuster; Juan Carlos García-Valdecasas

Hiliar cholangiocarcinoma is the most common type of cholangiocarcinoma, an represent around 10% of all hepatobiliary tumors. It is an aggressive malignancy, resectable in around 47% of the patients at diagnosis. Complete resection is the most effective and only potentially curative therapy, with a survival rate of less than 12 months in unresectable cases. Axial computerized tomography and magnetic resonance are the most useful image techniques to determine the surgical resectability. Clinically, jaundice and pruritus are the most common symptoms at diagnosis;preoperative biliary drainage is recommended using endoscopic retrograde cholangiography or percutaneous transhepatic cholangiography. Surgery using extended liver resections with an en bloc resection of the liver with vascular reconstruction is the technique with the highest survival. Complete resection with histologically negative resection margins (R0), nodal involvement and metastases are the most important prognostic factors.


European Surgical Research | 2016

Contents Vol. 56, 2016

Lars Bo Svendsen; Morten Bo Søndergaard Svendsen; Rikard Ambrus; Rune Broni Strandby; Michael Patrick Achiam; John F. Steffensen; Wouter Willaert; Tom Van Hoof; Wim Ceelen; Piet Pattyn; Katharina D'Herde; Francesca Tozzi; Henrik Thorlacius; Hanna Sternby; Hannes Hartman; Dorthe Johansen; Sara Regnér; Yusuke Sato; Satoru Motoyama; Yoshihiro Minamiya; Eylem Çağıltay; Ulvi Mehmet Meral; Umit Alakus; Murat Urkan; Orhan Üreyen; Nisa Cem Oren; Aylin Ozturk Meral; Mehmet Fatih Can; Erich K. Odermatt; Christiane Freytag

I. Alwayn, Halifax D.K. Bartsch, Marburg C. Bassi, Verona W.O. Bechstein, Frankfurt am Main J.A. Bradley, Cambridge M. Cikirikcioglu, Geneva P.-A. Clavien, Zurich U. Dahmen, Jena R.W.F. de Bruin, Rotterdam S. Fichtner-Feigl, Regensburg H. Friess, Munich G. Galata, London D.J. Gouma, Hilversum J.K. Habermann, Lübeck M. Heberer, Basel M. Heger, Amsterdam T. Hubert, Lille W.R. Jarnagin, New York, N.Y. J.C. Kalff, Bonn M.W. Laschke, Homburg/Saar H.-A. Lehr, Friedrichshafen C.M. Malata, Cambridge T. Minor, Bonn M. Morino, Torino J. Pirenne, Leuven A. Schachtrupp, Melsungen T. Schmitz-Rixen, Frankfurt a.M. R. Schramm, Munich L. Steinstraesser, Oldenburg A. Szijártó, Budapest R.H. Tolba, Aachen M. van Griensven, Munich T.M. van Gulik, Amsterdam M.A. Venermo, Helsinki M.H. Wilhelmi, Hannover D.C. Winter, Dublin Y. Yamamoto, Akita Clinical and Experimental Surgery


Pancreatology | 2018

What is the clinical impact of standard lymphadenectomy in G1-2 NET patients undergoing left pancreatectomy?

Fabio Ausania; Paula Senra del Río; Dimitri Dorcaratto; Miguel Angel Gómez-Bravo; Teresa González-Nicolás; Elena Martín; Luis Sabater; Alejandro Serrablo; Santiago Sánchez-Cabús; Antoni Tardío Baiges


Hpb | 2018

Preoperative tumour size predicts the risk of recurrence following pancreatectomy for G1–G2 neuroendocrine tumours: a multiinstitutional spanish study

Fabio Ausania; P. Senra; D. Dorcaratto; M.A. Gomez-Bravo; T. González-Nicolás; E. Martín; L. Sabater; Alejandro Serrablo; Santiago Sánchez-Cabús

Collaboration


Dive into the Santiago Sánchez-Cabús's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Joana Ferrer

University of Barcelona

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Josep Fuster

University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

José Fuster

University of Barcelona

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Pilar Taura

University of Barcelona

View shared research outputs
Researchain Logo
Decentralizing Knowledge